Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral acetazolamide for decongestion in chronic congestive heart failure
IRCT20230527058306N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Acetazolamide with Placebo (2 arms). Primary endpoints: Sodium to creatinine ratio, NT-proBNP level and 1 more. Started Jul 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on IRCT20230527058306N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230527058306N1.